Pegfilgrastim biosimilar (Juta Pharma)

培非格司亭生物类似药(Juta Pharma)

Report date: 2022/01/21 13:30:09

Base Information

Drug NamePegfilgrastim biosimilar (Juta Pharma)
Drug Alias Name非格司亭生物仿制药(Juta Pharma)Pegylated filgrastim (Juta Pharma)PEG-rmetHuG-CSF (Juta Pharma)培非格司亭生物仿制药(Juta Pharma)培非拉司亭生物仿制药(Juta Pharma) +[10
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2019/04/26
Country/TerritoryEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJuta Pharma
China Registration ClassN/A

Develop Information

Active CompaniesJuta Pharma Gmbh
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A